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INTRODUCTION 7 
Substantial evidence supports the role of cardiovascular disease (CVD) and coronary risk 8 
factors in both cognitive decline and dementia (1,2). Yet little is known regarding means of 9 
preserving cognitive health in this high-risk group, a group representing as much as 70% of those 10 
aged ≥ 65 years in the US (3). Certainly, diet is known to modulate cardiovascular processes (4), 11 
and thus would appear a plausible behavioral approach to also reducing cognitive decline in 12 
those with vascular conditions. While some previous studies have focused on individual nutrients 13 
such as antioxidants, omega 3 fatty acids or B vitamins both in healthy participants and those 14 
with vascular risk, clinical trials of these agents have not shown either major vascular (5-7) or 15 
neuroprotective (8-10) effects in aging. In contrast, there may be additive and interactive effects 16 
between individual dietary components within a dietary pattern, and both randomized trials 17 
(11,12) and cohort studies (13-15) have reported reduced cardiovascular outcomes with a 18 
Mediterranean diet pattern in particular, which is characterized by high intakes of fruits and 19 
vegetables, fish, cereals, legumes, and monounsaturated fat, moderate alcohol, and low amounts 20 
of meat and dairy products (16). Through modulation of vascular processes, Mediterranean diet 21 
may then potentially slow cognitive aging. However, there has been very limited prospective 22 
research on the Mediterranean diet and cognitive health (17-19), and to our knowledge, no data 23 
in those with prevalent vascular disease or risk factors. In fact, even factors which may help 24 
maintain cognition in healthy older persons, may not be equally effective in those with existing 25 
vascular disease, as pathology in the later is likely more severe and potentially less tractable. 26 
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Thus, the potential effect of Mediterranean diet on cognitive decline was specifically evaluated 27 
in older persons with vascular disease, utilizing data from the cognitive ancillary study among 28 
the oldest participants in the Women‟s Antioxidant Cardiovascular Study (WACS), a trial of 29 
secondary prevention of CVD. 30 
 31 
METHODS 32 
The Women‟s Antioxidant Cardiovascular Study (WACS) began in 1995-1996 („baseline‟) 33 
among 8171 American women, as a 2x2x2 randomized placebo-controlled trial of vitamin E, 34 
vitamin C, and beta-carotene supplementation for secondary prevention of CVD (20). Eligible 35 
participants were US female health professionals, aged ≥ 40 years, with prevalent CVD or ≥ 3 36 
coronary risk factors (i.e., parental history of premature myocardial infarction (MI), diabetes, 37 
hypertension, hyperlipidemia, and body mass index ≥ 30 kg/m2). Prevalent CVD included MI, 38 
stroke, revascularization procedures (i.e., percutaneous transluminal angioplasty, coronary artery 39 
bypass graft, carotid endarterectomy, or peripheral artery surgery), symptomatic angina pectoris, 40 
or transient cerebral ischemia. In 1998, a fourth arm for B vitamin supplementation (combined 41 
folic acid, vitamin B6, and vitamin B12) was added among 5442 women (21). Participants were 42 
94.0% Caucasian and 3.3% African-American. Until the scheduled end in 2005, they completed 43 
annual questionnaires on compliance, side effects, health, lifestyle and clinical endpoints. This 44 
study was approved by the institutional review board of Brigham and Women‟s Hospital, 45 
Boston, MA. Each participant gave a written informed consent. None of the supplements were 46 
found to reduce cardiovascular disease recurrence (20,21) or influence cognitive decline (22,23). 47 
 48 
Cognitive subcohort and study population 49 
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From 1998-2000, cognitive function were assessed using telephone interviews among 50 
participants then aged ≥ 65 years. Of the 3170 eligible women, 190 were unreachable, 156 51 
declined participation, and 2824 (95% of contacted women) completed the initial telephone 52 
cognitive assessment. These women received three follow-up assessments at two-year intervals 53 
until 2005; 93% completed at least two cognitive assessments, and 81% completed at least three 54 
among four. For the fourth assessment, 24% of participants were not contacted as only a short 55 
interval had passed between their third interview and the trial end. The mean time from the initial 56 
to the last cognitive assessment was 5.4 years (range 4.1–6.1 years). 57 
For this study on diet and cognitive decline, 320 participants among the 2824 with initial 58 
cognitive assessment were excluded because of incomplete dietary information. Thus, the 59 
analysis sample for the present study was comprised of 2504 women. 60 
 61 
Cognitive Assessment 62 
The telephone interview consisted of five cognitive tests. Global cognition was evaluated 63 
with the Telephone Interview of Cognitive Status (TICS) (24) (range 0 to 41 points), a telephone 64 
adaptation of the Mini-Mental State Examination (MMSE). Verbal memory was assessed with 65 
the TICS 10-word list (immediate and delayed recalls) and the East Boston Memory Test 66 
(immediate and delayed recalls) (25). A test of category fluency (26), in which women were 67 
asked to name as many animals as possible in one minute, was also administered. 68 
The primary outcome was the rate of change from the initial through the last assessment in 69 
a global composite score, computed as the mean of the z-scores from all cognitive tests. The 70 
secondary outcomes were the changes in TICS score, verbal memory composite score (mean of 71 
the z-scores from the immediate and delayed recalls of both TICS-10 word list and the East 72 
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Boston Memory Test), and category fluency score. Verbal memory is among the best predictors 73 
of Alzheimer disease (27), and category fluency partly measures executive function, which is 74 
associated with vascular disease. The means of the z-scores from the available relevant tests 75 
were used to derive the composite scores for participants who did not complete all tests (only 76 
0.5% of participants). Extensive evidence supports the face and clinical validity of this telephone 77 
cognitive instrument as previously developed (28). 78 
 79 
Mediterranean diet 80 
The Willett semi-quantitative food frequency questionnaire was administered at WACS 81 
baseline. The questionnaire asked about the usual consumption during the past year (nine 82 
possible response categories) of 116 food items with a specified portion size. It has been 83 
extensively studied for validity (29). The mean time from the food frequency questionnaire to the 84 
initial cognitive assessment was 3.5 years (range 3.1-4.4 years). This lag period likely has some 85 
benefits. First, since diet was assessed at somewhat younger ages, it is likely less influenced by 86 
“reverse” causation – that is, changes in diet due to underlying cognitive status. Moreover, 87 
biologically, diet at more remote timepoints is probably more relevant to brain health than more 88 
immediate diet, as cognitive decline develops over many years (27). 89 
A widely-used method based on a 0 to 9-point scale was implemented to evaluate the 90 
degree of individual adherence to a Mediterranean diet pattern (30-32), where higher scores 91 
indicated stricter adherence. First, dietary intakes were energy-adjusted using the residual 92 
method. Then, for each of nine major components of the Mediterranean diet (vegetables, 93 
legumes, fruits, cereals, fish, meat, dairy products, ratio of monounsaturated to saturated fat and 94 
alcohol), a value of zero or one was assigned, according to presumed level of health benefit. 95 
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Specifically, women whose consumption of vegetables, legumes, fruits, cereals, fish, and 96 
monounsaturated to saturated fat ratio was above the median consumption in the study 97 
population were assigned a value of one, and a value of zero otherwise. In contrast, women 98 
whose consumption of meat and dairy products was above the median consumption were 99 
assigned a value of zero and a value of one otherwise. Finally, for alcohol intake, women with 100 
mild-to-moderate alcohol consumption (from 5 to 25 g of alcohol per day) were assigned a value 101 
of one and a value of zero otherwise (31,32). The Mediterranean diet score was generated by 102 
adding all the binary component scores. Its mean was 4.2 (SD, 1.8) and its distribution was 103 
normal. This sum was then divided into three categories (low, middle and high), broadly 104 
corresponding to tertiles: 0-3; 4-5; 6-9. Mean intakes of consumption for the nine diet 105 
components are presented in Table 1. 106 
In secondary analysis, an alternate definition for the Mediterranean diet adherence was 107 
considered through a 0-55 point diet score used in a recent study of Mediterranean diet and 108 
cognitive decline (19). This adaptation from the score described by Panagiotakos et al. (33) was 109 
based on reported intakes of alcohol and 10 food groups: seven components consistent with the 110 
Mediterranean diet (nonrefined cereals, potatoes, fruits, vegetables, legumes / nuts / beans, fish, 111 
olive oil) and three „inconsistent‟ components (red and processed meats, poultry, full-fat cheese 112 
and other dairy). The scores for each component ranged from 1 to 5 based on the level of 113 
consumption frequency observed at the population level. 114 
To further assess the robustness of the results and susceptibility to recent changes in diet, 115 
subgroup analyses were conducted only among women who reported at WACS baseline that 116 
their diet changed very little in the past five years (n=847). 117 
 118 
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Covariates 119 
Annual questionnaires to WACS participants were used to obtain information on a wide 120 
variety of potential confounders including sociodemographic factors, health, medications and 121 
lifestyle factors plausibly linked with both cognitive decline and dietary habits. Variables 122 
introduced in the models as adjustment variables included: age (years), education (licensed 123 
practical nurse, vocational nurse or associate‟s degree; registered nurse degree or bachelor‟s 124 
degree; master‟s or doctoral degree), energy from diet (quartiles), marital status (married, 125 
divorced, widowed, single), physical activity (quartiles of weekly calories expended from 126 
exercise and climbing the stairs), use of multivitamin supplements (no, yes), smoking status 127 
(never, past, current), body mass index (quartiles), postmenopausal hormone therapy use (never, 128 
past, current), aspirin use exceeding 10 days in the previous month (no, yes), non-steroidal anti-129 
inflammatory drug use exceeding 10 days in the previous month (no, yes), history of depression 130 
(no, yes), cardiovascular profile at baseline (myocardial infarction, stroke, revascularization 131 
procedures, symptomatic angina pectoris, transient cerebral ischemia, no clinical disease), 132 
diabetes (no, yes), hypertension (no, yes on pharmaceutical treatment, yes without 133 
pharmaceutical treatment), hyperlipidemia (no, yes on pharmaceutical treatment, yes without 134 
pharmaceutical treatment), and randomization assignment for vitamin E (placebo, active), 135 
vitamin C (placebo, active), beta-carotene (placebo, active), and folate (not assigned, placebo, 136 
active). In numerous validation studies in populations similar to WACS, self-reported covariate 137 
data from studies of health professionals have proven to be highly valid. 138 
 139 
Statistical Analysis 140 
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First, participants‟ age and age-standardized characteristics at dietary assessment were 141 
compared across tertiles of Mediterranean diet score. Homogeneity was tested using p-values 142 
from Chi
2
 test or variance analysis depending on the covariate type (categorical or numeric). 143 
Then, general linear models for repeated measures with random intercepts and slopes were 144 
used to estimate the association of Mediterranean diet score with the annual rate of cognitive 145 
change. The longitudinal correlation in scores within subject was incorporated into the models 146 
using an unstructured covariance matrix. Linear trends across level of Mediterranean diet 147 
adherence were tested by assigning the median value to each of the three categories of the 148 
Mediterranean diet score as a continuous ordinal variable. Wald tests were used for statistical 149 
testing. All models were fitted by maximum likelihood method using the SAS software (SAS 150 
release 9.1, SAS Institute Inc., Cary, NC). 151 
Basic models included adjustment for age at initial cognitive assessment, educational 152 
attainment, and energy from diet. Full multivariable models further adjusted for WACS 153 
randomization assignments, and numerous lifestyle and health variables (as described above). 154 
Secondary analysis also adjusted for incident vascular events during follow-up. 155 
Given the possibility that age, education, depression, cardiovascular profile at baseline or 156 
cognitive status at initial assessment could modify the association between Mediterranean diet 157 
and cognitive decline, interaction terms for these variables and Mediterranean diet score were 158 
evaluated, and stratified analyses by these variables were conducted as well. Potential effect 159 
modifiers were defined as follows: age at first cognitive assessment (age 65 – 72 [n=1261] 160 
versus age 73 – 91 [n=1243]); highest attained education (licensed practical nurse, vocational 161 
nurse, associate‟s or registered nurse degree [n=1802] versus bachelor‟s or master‟s or doctoral 162 
degree [n=702]), history of depression at baseline (no [n=2128] versus yes |n=376]), baseline 163 
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cardiovascular status (CVD event [n=1882] versus risk factors only [n=622]) and cognitive 164 
status at first assessment (global cognitive score ≤ median [n=1252] versus global cognitive 165 
score > median [n=1252]). 166 
 167 
RESULTS 168 
In the study population, mean intakes of vegetables and legumes nearly doubled across 169 
tertiles of Mediterranean diet score and mean intakes of fruit, fish and grains increased by nearly 170 
50% (Table 1). Proportion of mild-to-moderate alcohol consumers was 9% in the first tertile, 171 
17% in the second and 30% in the third tertile of Mediterranean diet score. 172 
As expected, stricter adherence to the Mediterranean diet was linked with higher education, 173 
lower body mass index and generally healthier behaviors (e.g., greater physical activity, less 174 
smoking) (Table 2). Importantly, adherence to Mediterranean diet was not clearly associated 175 
with cardiovascular profile at WACS baseline (i.e., history of clinical MI, stroke, 176 
revascularization surgery, angina, or transient ischemic attack; history of diabetes; history of 177 
hypertension), suggesting that the severity of cardiovascular disease at baseline was not a major 178 
confounder in the present study. 179 
 180 
Mediterranean diet and cognitive change 181 
In both the basic-adjusted and multivariable-adjusted models, no significant differences 182 
were observed across the categories of the Mediterranean diet score in the mean annual rate of 183 
cognitive change for the global composite, TICS, verbal memory, or category fluency scores 184 
(Table 3). For example, the mean multivariable-adjusted difference (95% confidence interval 185 
(CI)) in rates of change in the global composite score was 0.01 (-0.01, 0.02) between the second 186 
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tertile and the first tertile of Mediterranean diet score, and 0.00 (-0.02, 0.01) between the top 187 
tertile and the first tertile (p-value for trend: 0.88). 188 
Results were not substantially altered when models were controlled for incident major 189 
cardiovascular events during follow-up. In addition, results were consistently null when the 190 
Mediterranean diet score was considered as a continuous variable (e.g., for the global composite 191 
score, mean difference per additional score point was -0.001 (p-value for trend=0.40). 192 
Also, no relations were observed with the alternate Mediterranean diet score: p-values for 193 
trend in cognitive change across tertiles were 0.58 for the global composite score, 0.25 for the 194 
TICS, 0.39 for the verbal memory score and 0.52 for the category fluency score. 195 
In the 847 women who reported stable diets (34% of the whole sample), effect estimates 196 
were virtually identical to those from the entire cohort, and there were no statistically significant 197 
associations between Mediterranean diet score and cognitive decline (e.g., for global composite 198 
score, mean difference (95% CI) between top and bottom tertiles of Mediterranean diet score 199 
was 0.00 (-0.03, 0.03), p-value for trend: 0.95). 200 
 201 
Effect modification and stratified analyses 202 
When investigating whether the associations with Mediterranean diet on cognitive decline 203 
may differ by baseline age, education, depression history at baseline, cardiovascular profile at 204 
baseline or cognitive score at first assessment, no significant interactions were found. Similarly, 205 
stratified analyses revealed no quantitative or qualitative differences between associations across 206 
strata of any of these variables (data not shown in table). 207 
 208 
 209 
 10 
DISCUSSION 210 
In this large prospective study of older women with vascular disease or at high vascular 211 
risk, no association was observed between adherence to the Mediterranean diet and cognitive 212 
decline over 5 years of follow-up. The absence of association was consistent across various 213 
cognitive outcomes, different definitions of Mediterranean diet scores and various strata of the 214 
population. There was no suggestion of an association among women who reported that their diet 215 
had been stable for at least the past 5 years. 216 
Of three large studies which have examined the association between Mediterranean diet and 217 
cognitive status in generally healthy participants, the two American studies have reported less 218 
cognitive decline (19) and lower risk of incident mild cognitive impairment (34) and incident 219 
Alzheimer disease (17) with greater adherence to a Mediterranean diet. However, in the French 220 
study (18), higher adherence to the Mediterranean diet was only weakly associated with slower 221 
decline in the MMSE and not consistently with other cognitive tests, and adherence was not 222 
related to risk of dementia. Thus, available results on the potential effect of Mediterranean diet in 223 
cognitive aging come from a limited number of inconsistent studies. What should be particularly 224 
underlined is the great variability across these studies in terms of “absolute” adherence to the 225 
Mediterranean diet : based on a comparison of the reported intakes of the nine components for 226 
the various categories of adherence, reference group in the present study population had higher 227 
intakes of vegetables, cereals and a much higher monounsaturated / saturated fat ratio than the 228 
other studies from the US, and was quite similar to that in the French cohort, which also found 229 
null associations with decline in cognition (except for MMSE) and with dementia. Moreover, it 230 
is possible that prevention is even more challenging in those with prevalent vascular disease or 231 
risk factors, as in WACS.  232 
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Limitations of this study should be discussed. The WACS dietary data were collected at 233 
trial baseline with a self-administered food frequency questionnaire, which although widely used 234 
in epidemiologic studies (29), is subject to misclassification of exposures. This misclassification 235 
is highly likely to be non-differential because diet was assessed 3.5 years before cognitive 236 
function assessment; such non-differential misclassification would bias results towards the null 237 
and may explain the observed lack of association between Mediterranean diet and cognitive 238 
decline. However, other studies of diet and cognitive decline using this food frequency 239 
questionnaire in populations of health professionals have reported strong relations between diet 240 
and cognition (35,36), indicating that misclassification is likely not a primary factor in the results 241 
here. Moreover, the two studies which have found associations between the Mediterranean diet 242 
and cognitive health (19,37) both used the same food frequency questionnaire to collect their 243 
dietary data. More importantly, the single assessment of dietary habits in late adulthood may not 244 
reflect the long-term dietary intakes of participants (in particular at midlife), which may be more 245 
etiologically relevant. This may be particularly true in this population of women at high 246 
cardiovascular risk, who were likely encouraged to change their diet at some point. To address 247 
this, the analyses were carefully adjusted for participants‟ cardiovascular profiles at WACS 248 
baseline. Indeed, those with clinical disease rather than only risk factors may be more motivated 249 
to change their diet. Also, subgroup analyses were conducted only among women who reported 250 
at baseline that their diet changed very little in the past five years. All of these approaches 251 
yielded findings very similar to the main analyses. Moreover, long-term dietary change is hard to 252 
achieve even in those with vascular risk (38,39) and no evidence was found in the data that 253 
Mediterranean diet adherence was related to level of clinical cardiovascular disease, suggesting 254 
that adoption of a Mediterranean diet was likely not determined or highly influenced by 255 
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underlying health. In addition, the study population showed fairly wide ranges in reported intake 256 
of many components in the Mediterranean diet (e.g., a doubling or near doubling in vegetables 257 
and legumes intakes from bottom to top tertile and 50% increase in fruit and grain intake), thus 258 
there was large variability in the Mediterranean diet across participants.  259 
Concerning the cognitive evaluation, a telephone assessment might lack validity. However, 260 
both reliability and validity studies of the telephone instrument (compared to in-person 261 
interviews) have provided convincing evidence of its utility to evaluate cognitive function in 262 
epidemiologic setting. Moreover, using the same or a similar telephone battery, significant 263 
associations with cognitive aging have been found with a large number of risk factors, including 264 
dietary variables establishing that the telephone instrument validly identifies risk factors for 265 
cognitive decline. Another limitation is that participants were mostly Caucasian, which precludes 266 
extending the findings to other ethnic minorities. Finally, residual confounding is always a 267 
possibility in observational studies, although the analyses were carefully adjusted on various 268 
potential confounders for the association between diet and cognitive change. 269 
In summary, in a large sample of community-dwelling women aged ≥ 65 years with pre-270 
existing cardiovascular disease or risk factors, no associations were observed between 271 
Mediterranean diet adherence and 5-year cognitive decline. Given the limited number of studies 272 
of Mediterranean diet and cognitive health, potential effects of Mediterranean diet in brain aging 273 
and dementia requires further evaluation, both in generally healthy participants and in those at 274 
higher risk of cognitive decline. To have a better view in the matter, it would be interesting to 275 
test various approaches for the Mediterranean diet, not only population-dependant approaches of 276 
adherence (such as the 0-9 point scale used here), but also individual ranking based on absolute 277 
dietary intakes. 278 
279 
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